9.535USD+6.30%Mkt Cap: 934.44M USDP/E: —Last update: 2026-06-01
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap934.44M USD
Enterprise Value870.91M USD
Revenue (TTM)98.99M USD
Gross Profit63.85M USD
Net Income (TTM)-171.30M USD
Revenue/Share1.001 USD
Last Price9.535 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees154
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.47
PEG—
EV/EBITDA-4.33
EV/Revenue8.80
P/S9.10
P/B7.88
EPS (TTM)-2.00
EPS (Forward)-0.96
52W Range
6.66023% of range18.90
52W High18.90 USD
52W Low6.660 USD
Profitability
Gross Margin75.77%
Oper. Margin-265.18%
EBITDA Margin-202.99%
Profit Margin-203.25%
ROE-149.92%
ROA-52.28%
Growth
Revenue Growth184.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-170.87M USD
CapEx (TTM)339.00K USD
FCF Margin-99.28%
FCF Yield-10.52%
Net Debt-29.77M USD
Net Debt/EBITDA0.15
Balance Sheet
Debt/Equity0.84
Current Ratio4.94
Quick Ratio4.64
Book Value/Sh1.151 USD
Cash/Share2.024 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)28.80 USD
Target Range25.00 USD – 32.00 USD
# Analysts5
Ownership
Shares Out.99.30M
Float42.45M
Insiders16.29%
Institutions95.48%
Short Interest
Short Ratio13.9d
Short % Float37.65%
Short % Out.26.09%
Shares Short25.91M
Short (prev mo.)26.76M
Technical
SMA 508.212 (+16.1%)
SMA 2009.691 (-1.6%)
Beta0.80
S&P 52W Chg27.70%
Avg Vol (30d)1.79M
Avg Vol (10d)2.03M
Technical Indicators
RSI (14)58.1
MACD0.0744
MACD Signal-0.0483
MACD Hist.+0.1226
BB Upper9.656 USD
BB Middle8.370 USD
BB Lower7.084 USD
BB Width30.73%
ATR (14)0.5818 USD
Vol Ratio (20d)0.72x